Skip to main content
OpenTrials

Clinical trial condition

Gastrointestinal Stromal Tumors

Explore clinical trials studying Gastrointestinal Stromal Tumors. Study availability and eligibility vary by location and protocol.

244 public trials 45 recruiting studies
Refine in advanced search Browse all conditions

Gastrointestinal Stromal Tumors trial results

Completed

A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

NCT01294202

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations
  • Arizona Cancer Center at UMC North Tucson, Arizona, United States
  • Robert H. Lurie Cancer Center of Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Study to Allow Access to Nilotinib for Patients Who Are on Nilotinib Treatment in a Novartis-sponsored Study

NCT01735955

Conditions
Acute Lymphoblastic Leukemia (ALL), Albinism, Amino Acid Metabolism, Inborn Errors, +41 more
Locations
  • Novartis Investigative Site Albany, New York, United States
  • Novartis Investigative Site Houston, Texas, United States
  • Novartis Investigative Site Vienna, Austria
  • Novartis Investigative Site Vancouver, British Columbia, Canada
View all 33 locations
View Trial Details
Completed

Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)

NCT02260505

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
Locations
  • Institut Paoli-Calmettes Marseille, Bouches Du Rhône, France
  • Centre Hospitalier Universitaire La Timone Marseille, Bouches Du Rhône, France
  • Centre Georges François Leclerc Dijon, Côte d'Or, France
  • CHRU de Besançon - Hôpital Minjoz Besançon, Doubs, France
View all 17 locations
View Trial Details
Completed

A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

NCT02571036

Conditions
Advanced Cancers, Advanced Systemic Mastocytosis, Bronchial Neoplasms, +53 more
Locations
  • Honor Health (GIST, mastocytosis, other solid tumors) Scottsdale, Arizona, United States
  • UCLA Hematology Center (mastocytosis) Los Angeles, California, United States
  • UCLA (glial malignancies only) Los Angeles, California, United States
  • Stanford University Comprehensive Cancer Center (GIST) Palo Alto, California, United States
View all 26 locations
View Trial Details
Completed

Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers

NCT02034110

Conditions
Biliary Tract Diseases, Biliary Tract Neoplasms, Blood Protein Disorders, +35 more
Locations
  • Novartis Investigative Site Little Rock, Arkansas, United States
  • Novartis Investigative Site Santa Monica, California, United States
  • Novartis Investigative Site Bethesda, Maryland, United States
  • Novartis Investigative Site Boston, Massachusetts, United States
View all 41 locations
View Trial Details
Completed

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

NCT00764595

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +12 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Aichi Medical University Nagoya, Aichi-ken, Japan
  • Hirosaki University, School of Medicine Hirosaki, Aomori, Japan
  • National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan
View all 36 locations
View Trial Details
Completed

Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

NCT00769782

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +12 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Aichi Medical University Nagoya, Aichi-ken, Japan
  • Hirosaki University, School of Medicine Hirosaki, Aomori, Japan
  • National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan
View all 37 locations
View Trial Details

Related conditions